Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

ATAAA repeat upstream of glutathione S-transferase P1 and prostate cancer risk.

Platz EA, Krithivas K, Kantoff PW, Stampfer MJ, Giovannucci E.

Urology. 2002 Jan;59(1):159-64.

PMID:
11796315
2.

Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history.

Rebbeck TR, Wang Y, Kantoff PW, Krithivas K, Neuhausen SL, Godwin AK, Daly MB, Narod SA, Brunet JS, Vesprini D, Garber JE, Lynch HT, Weber BL, Brown M.

Cancer Res. 2001 Jul 15;61(14):5420-4.

3.

Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men.

Krithivas K, Yurgalevitch SM, Mohr BA, Wilcox CJ, Batter SJ, Brown M, Longcope C, McKinlay JB, Kantoff PW.

J Endocrinol. 1999 Jul;162(1):137-42.

PMID:
10396030
4.

CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in U.S. physicians.

Giovannucci E, Stampfer MJ, Chan A, Krithivas K, Gann PH, Hennekens CH, Kantoff PW.

Prostate. 1999 May;39(2):130-4.

PMID:
10221569
5.

Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat.

Rebbeck TR, Kantoff PW, Krithivas K, Neuhausen S, Blackwood MA, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Weber BL, Brown M.

Am J Hum Genet. 1999 May;64(5):1371-7.

6.

The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia.

Giovannucci E, Platz EA, Stampfer MJ, Chan A, Krithivas K, Kawachi I, Willett WC, Kantoff PW.

Urology. 1999 Jan;53(1):121-5.

PMID:
9886600
7.

The androgen receptor gene GGN microsatellite and prostate cancer risk.

Platz EA, Giovannucci E, Dahl DM, Krithivas K, Hennekens CH, Brown M, Stampfer MJ, Kantoff PW.

Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):379-84.

8.

Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma.

Ghossein RA, Rosai J, Scher HI, Seiden M, Zhang ZF, Sun M, Chang G, Berlane K, Krithivas K, Kantoff PW.

Urology. 1997 Jul;50(1):100-5.

PMID:
9218026
9.

The CAG repeat within the androgen receptor gene and its relationship to prostate cancer.

Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Dahl D, Brufsky A, Talcott J, Hennekens CH, Kantoff PW.

Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3320-3. Erratum in: Proc Natl Acad Sci U S A 1997 Jul 22;94(15):8272.

10.

A polymorphism of the 5 alpha-reductase gene and its association with prostate cancer: a case-control analysis.

Kantoff PW, Febbo PG, Giovannucci E, Krithivas K, Dahl DM, Chang G, Hennekens CH, Brown M, Stampfer MJ.

Cancer Epidemiol Biomarkers Prev. 1997 Mar;6(3):189-92.

11.

Constitutive expression of high levels of prostate-specific antigen in the absence of prostate carcinoma.

Kibel AS, Krithivas K, Shamel LB, Kantoff PW, DeWolf WC.

Urology. 1996 Nov;48(5):741-6.

PMID:
8911518
12.

Detection of circulating tumor cells in men with localized prostate cancer.

Seiden MV, Kantoff PW, Krithivas K, Propert K, Bryant M, Haltom E, Gaynes L, Kaplan I, Bubley G, DeWolf W, et al.

J Clin Oncol. 1994 Dec;12(12):2634-9.

PMID:
7527455

Supplemental Content

Loading ...
Support Center